Ardelyx Inc (ARDX)
6.505
+0.20
(+3.09%)
USD |
NASDAQ |
Apr 26, 14:26
Ardelyx Cash from Investing (TTM): -131.25M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -131.25M |
September 30, 2023 | -100.24M |
June 30, 2023 | -68.38M |
March 31, 2023 | 6.306M |
December 31, 2022 | 18.42M |
September 30, 2022 | 39.07M |
June 30, 2022 | 58.04M |
March 31, 2022 | 50.80M |
December 31, 2021 | 50.95M |
September 30, 2021 | 25.28M |
June 30, 2021 | 16.74M |
March 31, 2021 | 21.93M |
December 31, 2020 | -31.44M |
September 30, 2020 | -83.33M |
June 30, 2020 | -69.48M |
March 31, 2020 | -57.49M |
December 31, 2019 | 23.37M |
September 30, 2019 | 101.02M |
June 30, 2019 | 87.67M |
March 31, 2019 | 1.222M |
December 31, 2018 | -29.89M |
Date | Value |
---|---|
September 30, 2018 | -40.86M |
June 30, 2018 | -36.15M |
March 31, 2018 | 41.19M |
December 31, 2017 | 65.29M |
September 30, 2017 | -5.159M |
June 30, 2017 | -91.32M |
March 31, 2017 | -107.91M |
December 31, 2016 | -131.08M |
September 30, 2016 | -72.30M |
June 30, 2016 | -1.629M |
March 31, 2016 | -2.599M |
December 31, 2015 | -3.454M |
September 30, 2015 | -4.032M |
June 30, 2015 | -3.44M |
March 31, 2015 | -2.817M |
December 31, 2014 | -1.856M |
September 30, 2014 | -0.824M |
June 30, 2014 | -0.757M |
March 31, 2014 | -0.302M |
December 31, 2013 | -0.278M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-131.25M
Minimum
Dec 2023
101.02M
Maximum
Sep 2019
-2.212M
Average
18.42M
Median
Dec 2022
Cash from Investing (TTM) Benchmarks
Nektar Therapeutics | 139.56M |
Omeros Corp | 27.45M |
Vistagen Therapeutics Inc | -0.5606M |
Karyopharm Therapeutics Inc | 7.94M |
Adverum Biotechnologies Inc | 96.88M |